Impact BioMedical Inc.

AMEX: IBO · Real-Time Price · USD
0.58
0.01 (2.29%)
At close: Aug 15, 2025, 3:59 PM
0.56
-2.75%
After-hours: Aug 15, 2025, 07:32 PM EDT

Impact BioMedical Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-24.77M -4.41M -10.5M -3.87M
Depreciation & Amortization
1.12M 1.12M 266.4K 69.86K
Stock-Based Compensation
19K n/a 903.54K n/a
Other Working Capital
-300K 271K -33.31K -561.84K
Other Non-Cash Items
20.29M n/a 2.79M 829.56K
Deferred Income Tax
33K n/a 2.71M n/a
Change in Working Capital
-608K 436K -507.7K -281.93K
Operating Cash Flow
-3.92M -2.85M -4.33M -3.25M
Capital Expenditures
n/a -18K -95.68K n/a
Cash Acquisitions
n/a n/a -2.05M n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
2K 3K 54.78K -42.93K
Investing Cash Flow
2K -15K -2.09M -42.93K
Debt Repayment
2.19M 2.87M n/a n/a
Common Stock Repurchased
n/a n/a n/a -46.45K
Dividend Paid
n/a n/a n/a -410K
Other Financial Acitivies
n/a n/a 1.28M 620.14K
Financial Cash Flow
5.92M 2.87M 7.01M 3.38M
Net Cash Flow
2M -1K 583.85K 89.61K
Free Cash Flow
-3.92M -2.87M -4.43M -3.25M